Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Oral Oncology|October 1, 2016
nab-Paclitaxel, cisplatin, and 5-fluorouracil followed by concurrent cisplatin and radiation for head and neck squamous cell carcinomaDouglas Adkins, Jessica Ley, Loren Michel, et al.
Head & Neck|February 21, 2019
Patterns of care and survival outcomes for laryngeal small cell cancerAlexander J Lin, Prashant Gabani, Ben Fischer-Valuck, et al.
Oral Oncology|October 28, 2023
Neighborhood socioeconomic status and race are associated with incidence disparities in oral cavity cancersSalma Ramadan, Jake J Lee, Ray Wang, et al.
Oral Oncology|August 12, 2017
nab-Paclitaxel-based induction chemotherapy with or without cetuximab for locally advanced head and neck squamous cell carcinomaDouglas Adkins, Jessica Ley, Peter Oppelt, et al.
The Laryngoscope|May 12, 2019
Extranodal extension is a strong prognosticator in HPV-positive oropharyngeal squamous cell carcinomaEric Bauer, Angela Mazul, Rebecca Chernock, et al.
Medical Oncology (Northwood, London, England)|October 10, 2019
nab-Paclitaxel-based induction chemotherapy followed by cisplatin and radiation therapy for human papillomavirus-unrelated head and neck squamous-cell carcinomaKai C C Johnson, Jessica Ley, Peter Oppelt, et al.
JAMA Otolaryngology-- Head & Neck Surgery|March 29, 2019
Association of Posttreatment Lymphopenia and Elevated Neutrophil-to-Lymphocyte Ratio With Poor Clinical Outcomes in Patients With Human Papillomavirus-Negative Oropharyngeal CancersAlexander J Lin, Margery Gang, Yuan James Rao, et al.
Cancer Medicine|January 27, 2015
Nab-paclitaxel-based compared to docetaxel-based induction chemotherapy regimens for locally advanced squamous cell carcinoma of the head and neckAmy Schell, Jessica Ley, Ningying Wu, et al.
The Laryngoscope|June 3, 2022
Post-operative Outcomes in Pediatric Patients Following Facial Reconstruction With Fibula Free FlapsAllison A Slijepcevic, Mark K Wax, Matthew Hanasono, et al.
Head and Neck Pathology|December 28, 2016
Correlation of Ki-67 Proliferative Antigen Expression and Tumor Response to Induction Chemotherapy Containing Cell Cycle-Specific Agents in Head and Neck Squamous Cell CarcinomaJonathan Chatzkel, James S Lewis, Jessica C Ley, et al.
Pageof 3